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Abstract: Inflammatory bowel disease (IBD) consists of Crohn’s disease and ulcerative colitis, chronic
conditions involving inflammation and ulceration of the gastrointestinal tract. Individuals with IBD
may be susceptible to experiencing health-related stigma: experienced, perceived, or internalised
social exclusion, rejection, blame, or devaluation resulting from negative social judgements based on
the disease. This qualitative research synthesis draws together findings from 38 studies describing
lived experiences to develop a unified interpretative account of the experience of stigma in IBD. Anal-
ysis developed two categories: ‘The IBD journey’ explores the dynamic ways in which having IBD
impacted on individuals’ self-identity and ‘a need to be understood’ examines the tension between
wanting to be understood whilst feeling their true experiences needed to be hidden from or were
misjudged by the social sphere. The overarching concept ‘feeling of otherness’ highlights that, rather
than a static, binary experience, individuals moved across a continuum ranging from the excluding
experience of feeling stigmatised and othered, to the inclusive experience of integration. Individuals
fluctuated along this continuum across different physical, social, and health contexts. Psychological
adjustment to IBD, drawing on experience of adaptive coping, and reconnecting with valued others
through illness disclosure strengthened stigma resistance during more challenging times.
Keywords: stigma; inflammatory bowel disease; colitis; ulcerative; Crohn’s disease; meta-synthesis;
patient experiences; qualitative research
1. Introduction
Inflammatory bowel disease (IBD) consists of Crohn’s disease and ulcerative colitis,
chronic conditions involving inflammation and ulceration of the gastrointestinal tract.
Symptoms include increased frequency and urgency to defecate, severe abdominal pain,
blood in stools, weight loss, fatigue, and in some cases joint swelling/pain, eye inflamma-
tion, delayed puberty, growth delay, and perianal disease [1]. Individuals often experience
periods of active symptoms or ‘flare-ups’ of severe symptoms and periods of remission [2].
IBD has accelerated in prevalence over recent years worldwide, surpassing 0.3% of the
population in North America and Europe [3]. Although there is currently no cure for
IBD, immunosuppressants, corticosteroids, and biological therapy can produce periods
of symptom-free remission, though the medications themselves have side effects, such as
increased appetite and weight gain, acne, increased risk of infections, low mood, anxiety,
irritability, upper respiratory tract infections, headaches, abdominal pain, and nausea [4,5].
For those with complex or treatment-resistant presentation, surgical intervention may be
required [1].
IBD can lead to a complex interplay of physical and psychological consequences.
The psychosocial impacts of IBD are substantial and can be severely debilitating [6].
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These include reduced quality of life, impaired interpersonal relationships, and increased
prevalence of depression and anxiety [7–10]. It has long been suggested that stress,
which can be caused both directly by IBD and indirectly by the additional challenges
and burden it places on individuals, adversely affects the course of IBD by increasing
disease activity [11,12]. Patients also report that their disease worsens when they feel
anxious or depressed [13]. Stigma may contribute to, or further exacerbate, the complex
physical, psychological, and social burden of IBD [14]. It is therefore important to better
understand the role of stigma as a psychological process within the IBD illness experience,
as this may help to improve objective and subjective indicators of the disease.
Stigma is a social construction that involves de-valuing an individual or group based
on an attribute that characterises them as different [15]. It is exemplified by a convergence
of labelling, cultural beliefs, disconnection, status loss, and discrimination [16]. People may
experience stigma in relation to a number of enduring features of their identity, including
their health. Weiss [14] offers a focussed definition of health-related stigma as a process of
experienced, perceived, or anticipated social exclusion, rejection, blame, or devaluation
resulting from a medically unwarranted adverse social judgement about an individual or
group on the basis of identification with a particular health condition. Health-related stigma
is prevalent across a number of chronic health conditions, most notably mental health,
HIV/AIDS, and leprosy, but also in diabetes, asthma, epilepsy, multiple sclerosis, pain
disorder, fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome [17,18].
Health-related stigma is also highly prevalent in people with IBD [19,20]. As the nature
and impact of stigma is likely to vary across different health conditions [14], it is important
to understand this phenomenon within the context of IBD.
Factors around disruptiveness, aesthetic qualities, concealability, disease course, ori-
gin, and danger, have been suggested as making conditions susceptible to health-related
stigma [21] and may be applicable within IBD. Lack of awareness and understanding about
the level of disability and chronicity of the disease, its cause, and the often hidden symp-
toms can result in individuals not being believed or being blamed for their condition [20].
IBD is a disease impacting the bowels, a taboo topic which is often viewed with disgust at
a societal level [22]. Although a generally unseen condition, unpredictable ‘flare-ups’ can
reveal noticeable, aesthetically displeasing, and disruptive symptoms or behavioural con-
sequences, for example increased frequency and urgency to defecate resulting in increased
toilet use and disruption to activities or social interactions. Some symptoms may be viewed
as socially undesirable because they do not conform to sociocultural rules and expectations
about bowel control and the private nature of bowel movements and faeces [23,24].
Stigma is multi-faceted, involving three key domains: enacted (direct experience of
social discrimination), perceived (how much individuals feel others hold stigmatising
beliefs or attitudes toward them), and internalised (the belief that negative attitudes or
stereotypes are deserved, accurate and apply to oneself), [17]. Enacted stigma has not
been well explored in IBD. However, a small number of studies found that individuals
report being treated differently by others within work-related contexts [19,20]. Perceived
stigma was more commonly reported in IBD, with individuals describing that family,
friends, co-workers, teachers, healthcare professionals, and the broader community do not
understand or take their condition seriously [19,20]. This may suggest that individuals
do not commonly experience direct enactment of the stigmatising beliefs or attitudes they
perceive others to hold, though it is difficult to draw clear conclusions due to the dearth of
literature exploring enacted stigma. Mild levels of internalised stigma involving feeling
unclean and damaged were reported by individuals with IBD, particularly by those in an
active disease phase [19,20]. Stigma has been found to have a negative impact on a range
of physical and mental health outcomes in IBD, including quality of life, psychological
wellbeing, self-esteem and self-efficacy, health-seeking behaviour, treatment adherence,
and relationships with healthcare professionals [19,20,25]. Whilst the perception that others
hold negative views alone can reduce well-being, internalised stigma may result in the
poorest psychological outcomes [20].
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More recently stigma resistance has also been examined, with some individuals
showing an adaptive response involving the ability to adjust to and even flourish in the face
of adverse stigma experiences [25]. High levels of resistance to stigma have been reported
in IBD, indicating that many individuals do not internalise the stigmatising attitudes they
perceive others to hold into their own identity [20]. Although not yet well understood,
social support, length of illness, public awareness, extraintestinal symptoms, educational
level, and urban dwelling have been suggested as influencing stigma resistance [19].
Whilst a growing body of research has begun to document the prevalence and impact
of stigma in IBD, the process of when, how, and why different forms of stigma impact these
individuals is less well understood. A fuller understanding of the process of health-related
stigma in IBD may contribute to intervention approaches that challenge and overcome
stigma and foster resilience to stigma in those impacted, as have been successfully devel-
oped in other health conditions such as HIV/AIDS, mental illness, leprosy, tuberculosis,
and epilepsy [26]. Qualitative research is well positioned for developing an understanding
of the personal, contextualised, and nuanced causes, impacts of, and responses to stigma in
those with IBD [27]. An emerging qualitative literature has begun to explore the lived expe-
riences of stigma in IBD [23,28–31]. However, given the impact of stigma on wide-ranging
aspects of life, the concept is also apparent within broader accounts of illness experiences
in IBD where stigma was not the primary focus. This work seeks to build upon previous
quantitative and mixed-methods reviews of stigma in IBD [19,20,25] by drawing together
qualitative first-hand accounts from individuals across a range of cultural contexts, ages,
symptom severity, and disease presentation to develop a unified account of the experience
of stigma in IBD from the perspective of individuals living with the disease.
Aim
This qualitative research synthesis employs a rigorous method for seeking greater
meaning about the lived experiences of stigma and IBD through analysis, synthesis, and in-
terpretation of a wider body of existing qualitative literature [32]. This review aims to
not only systematically identify and summarise findings from previous literature but to
develop novel interpretations and insights, providing an original framework of understand-
ing stigma that is broad enough to enable findings to be generalised across individuals
with IBD, yet focussed enough to provide contextually relevant theoretical insight [33,34].
Research question: What are the lived experiences of stigma in individuals with
inflammatory bowel disease?
2. Materials and Methods
This review was carried out as a qualitative research synthesis [32] which aimed to
identify, synthesise, and interpret the wider body of existing lived experience research to
provide a new in-depth framework of understanding health-related stigma in individuals
with IBD. The review was reported using the ENTREQ qualitative research statement [35].
2.1. Search Strategy
A systematic literature search was conducted by E.J. in May 2020. Five electronic
databases (Medline, PsycINFO, Web of Science Core Collection, Scopus, and CINAHL)
were purposively selected to retrieve articles within the fields of psychology, health, and
nursing. Search terms are outlined in Table 1. Additional searches were conducted using
citation tracking, manually searching reference lists of relevant articles, and forward citation
searching. Database alerts were reviewed until May 2021 and identified five subsequently
published articles for inclusion.
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Note: Search terms within each construct (IBD, experience, and qualitative) were combined with OR whilst search
terms between each construct were combined with AND. The * was used to search for all forms of the word that
start with the same letters.
2.2. Study Eligibility
Studies were included if the article was (i) published in English language; (ii) pub-
lished in a peer reviewed journal; (iii) primary research; (iv) qualitative research, or mixed-
methods research if qualitative data were reported distinctly (i.e., studies which generate
understanding of subjective experience using an interpretative framework, as defined by
Noblit and Hare [36]); (v) study participants had a diagnosis of IBD, including Crohn’s
disease or ulcerative colitis; (vi) study addressed a domain of stigma, as proposed by
Weiss et al. [14]; (vii) reported findings were evidenced with participant quotes. There were
no restrictions on age of study participants or publication date. Studies were excluded for
(i) inclusion of other chronic illness; (ii) focus on a discrete aspect of IBD not universally
experienced (e.g., surgery and stoma).
2.3. Literature Screening
Articles were collated and duplicates removed. The remaining articles (n = 2860) were
screened by title and abstract, with 52 selected for full-text screening against the eligibility
criteria. Thirty-eight studies were eligible for inclusions in analysis. The screening process
is summarised in Figure 1.
2.4. Study Characteristics
The 38 studies included in the review were published from 1996 to 2021. Fifteen
studies were conducted in the United Kingdom, five in Canada, five in Sweden, four in
the United States, two in New Zealand, two in China, and one each in Hong Kong, Spain,
Turkey, and Malta, and one in both the UK and Australia. A total of 1225 participants with
an age range of 7–83 years were included. Thirty-one studies included an adult population,
five included adults and adolescents, and two included children and adolescents. Seven
studies focused on CD only, five on UC only and 26 studies included people with both CD
and UC. Twenty-nine studies used individual interviews, one used focus group interviews,
four combined individual and focus group interviews, one used video diaries and focus
groups, one used interviews, friendship maps, and photographs, one used journal logs,
and one used an online survey.
2.5. Quality Assessment
Quality of the included studies was assessed though the Critical Appraisal Skills
Programme [38] CASP Qualitative Checklist, a suitable tool for examining quality across
a range of qualitative methodologies [35]. All studies were reviewed independently by
E.J. and K.M. who conferred findings. All included studies met all of the criteria in the
CASP Checklist with the following exceptions (see Supplementary Table S1). Justification
for methodological approach was not explicit in one study [39]. Consideration of the rela-
tionship between the researcher and the participants was unclear in 14 studies [29,39–51].
In one study ethical consideration was not clear [42]. One study provided ethical consider-
ation but did not state if ethical approval was obtained [52]. Two studies did not provide
a full description of analysis [30,39] and one did not provide a justification for analytic
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approach [53]. Despite these considerations, an appropriate level of quality was achieved
across all studies and thus none were excluded on quality grounds.
2.6. Data Extraction
General characteristics were extracted to provide an overview of studies, consisting
of authors and date of publication; study location; study population and number; aim
of study; method of data collection; method of data analysis; key results or themes (re-
ported in Table 2). Relevant data was then extracted from participant quotes and authors
interpretations in the results. This approach allowed for analysis of rich accounts of orig-
inal data alongside a triple hermeneutic approach which takes account of context to aid
understanding [32].
Figure 1. PRISMA flow diagram of the selection process. Adapted from the Preferred Reporting Items for Systematic
Review and Meta-analyses (PRISMA) flow diagram [37].
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Table 2. Attributes of included studies.
Author and Date Location ofResearch
Population
and Number Aim of Study Data Collection Data Analysis * Results/Findings
Alexakis et al.
(2015) [54] UK















Parents, families, and the wider community
Education
Healthcare services and support







with IBD go about
deciding if and when to





To disclose or conceal: making the decision
When to tell: factors influencing disclosure decisions
- Gaining adequate knowledge about one’s
illness
- Severity of the illness







To gain a deeper
understanding of the
adolescents’ experiences













Role identification as a child/patient
Role identification as an adult
Carter et al. (2020) [55] UK











To tell or not to tell
Controlling the flow: the who, when, what, and how
of telling
Reactions and responses to telling: anticipated and
actual
Cho et al. (2018) [56] Canada





life needs of young adults
with IBD.
Interviews. Constant comparativemethod.





Int. J. Environ. Res. Public Health 2021, 18, 8038 7 of 28
Table 2. Cont.
Author and Date Location ofResearch
Population
and Number Aim of Study Data Collection Data Analysis * Results/Findings











One main theme: Reconciliation of the self in IBD
Three sub-themes:
Living with uncertainties and contradictions
I’ve got it or it’s got me






To explore fatigue, its
impact on daily life and
the strategies used to
ameliorate the symptom,
as described by people
with IBD.
Focus group interviews. Inductive thematicframework.
Five themes:










To address unmet needs
regarding psychosocial
aspects of food, eating,




Personal experience of relationship between IBD and
food
Managing diet to control IBD and its symptoms
Impact of food-related issues on everyday life
Acceptance and normalisation of food and its
impact in IBD
Sources of information and support
Daniel (2002)
[43] Canada
Young adults with IBD
(18–24 yrs)
n = 5
To expand awareness and
enhance empirical
understanding of the
young adult IBD patient’s







Themes in the study compared with King’s concepts
in the Personal System, Interpersonal System and
Social System












A flare phase of the disease
A remission period
Coping behaviours




To describe the impacts of
IBD from a patient
perspective.
Focus groups and
individual interviews. Grounded theory.
A conceptual model of impacts including:
Immediate impacts
Lifestyle impacts
Impacts of daily activities
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Table 2. Cont.
Author and Date Location ofResearch
Population
and Number Aim of Study Data Collection Data Analysis * Results/Findings
Dibley et al. (2014) [29] UK




To explore the parallels
between coming out
about sexual identity and
IBD in order to compare
GLP IBD-related concerns
with those in the non-gay
IBD community and to








IBD and GL life
Identity and coming out




To explore the lived








Being in and out of control
Relationships and social support
Mastery and mediation
Dibley et al. (2019) [28] UK
Adults with IBD
(21 – 64 yrs)
n = 18
An exploration of the
experience and meaning









Being the Disease/Having the Disease
Amplification, Suffering, and Loss
Constitutive Pattern: Lacking
Acknowledgment/Being Acknowledged












Uncertainty surrounding the length of time between
exacerbations of symptoms
Fear and humiliation accompanying stool
incontinence
The desperate need to find successful treatment and
return to normal life
The profound effect of family life, social life, and
work
The feeling of being controlled by the disease
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Table 2. Cont.
Author and Date Location ofResearch
Population






To understand the lived
experience of CD. Interviews. Colaizzi’s framework.
Five themes:
Self-protection against the unknown cause
self-training
Learning to live with CD
Perceived losses associated to CD
Relationship with others














Grounded theory. Emergent core concept:‘Health-related normality’




To explore the experience
of people with IBD and
elevated symptoms of
anxiety and low mood





Two themes related to anxiety: under performance;
preventing an accident
Two themes related to low mood: lack of
understanding; stigma
One main theme for type of psychological help
desired: Expertise and understanding




To investigate the specific
disease-related stress in
individuals with IBD,
how they cope with this





Stress: disease-related stress and relations to others
Coping: behavioural strategies, social strategies and
emotional strategies
Need for help or support: instrumental support and
emotional support.
Lynch and Spence











Stress as integral to living with CD
The paradoxical relationship between fear and hope
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Table 2. Cont.
Author and Date Location ofResearch
Population
and Number Aim of Study Data Collection Data Analysis * Results/Findings
Mikocka-Walus et al.
(2020) [53]
UK (n = 13) and




To explore the lived
experience and healthcare












Bidirectional relationship between IBD and mental
health, Need for healthcare integration
Lack of awareness about the disease
Three Australia themes:
The ‘vicious cycle’ of IBD and psychosocial health
The need for biopsychosocial healthcare integration
and The stigma of a hidden disease
Moore (2013) [63] UK Adult with UC (20 yrs)n = 1
To document the author’s
lived experience while in
the midst of an acute
flare-up of UC.






To identify parents’ views
on how IBD affects people
in their parenting role;
effects parents with IBD
have noticed in their
children; ways of dealing
with any difficulties in
parenting; support
needed by parents with
IBD.
Individual interviews




Ways of dealing with difficulties
Support received from services







To understand the lived
experience and elements
of quality of life as





Concerns relating to IBD symptoms and treatments
Vulnerability and lack of control
Perceiving the self negatively as different than peers
Benefits of social support
Personal resources in coping




To understand the impact
of CD on various aspects
of daily life from the
perspective of patients
living with CD.
Video diaries and focus
groups. Descriptive summaries.
Impact of CD on various aspects of life:
General impact of CD
Relationship with provider
Psychological impact of CD
Social impact of CD
Impact of CD on activities
Impact of CD on professional life
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Table 2. Cont.
Author and Date Location ofResearch
Population







To understand how a
partner’s diagnosis of CD
is perceived to affect
couple relationship
functioning and









Four areas of experiences:
Diagnosis
Biopsychosocial wellbeing







To identify and describe
the meaning of quality













To describe how patients
living with IBD
experience critical
incidents in daily life in
relation to their disease
and symptoms.
Interviews. Critical incidenttechnique (inductive).
Five categories:
Losing bowel control
Having a body that smells
Being unable to meet own and others’ expectations
Not being believed or seen
Experiencing frustration due to side effects and
ineffective treatment.
One main area describing the overall result:






To explore the positive
and negative changes
patients with IBD have
experienced since
diagnosis.
Online survey. Grounded theory.
Five themes related to positive changes:
Interpersonal Relations, Personal Growth, Valuing
Life, New Life Paths, and Spiritual Growth.
Three themes related to negative changes:
Freedom Restrictions, Psychological Side Effects, and
Social Isolation




To explore how adults








Journey to confirming and accepting diagnosis
Importance of the relationship with the healthcare
team
Support from others
Learning how to manage IBD
Care at a distance
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Table 2. Cont.
Author and Date Location ofResearch
Population
and Number Aim of Study Data Collection Data Analysis * Results/Findings






image changes in patients








Being a constrained person
Being a flawed person
Being a disliked person
Being an alienated person
Being a reconciled person






To explore the illness
experiences of patients












One core category: Regaining normality




To explore the experiences







Living with physical discomfort
Emotional turmoil in living the experience
Social interactions




To explore how stigma is
discursively constructed
by young adults, with a







Representations showed both felt stigma and enacted
stigma; principally related to the perceived taboo
surrounding the symptoms of their condition, which












Daily struggle to adapt and be perceived as normal
Four subthemes:
Being healthy despite the symptoms
Being healthy despite being afraid
Being healthy despite a sense of being different
Being healthy despite needing support




To understand how the
lives of people with CD
are affected.
Interviews. Theoretical thematicanalysis.
Thirteen main need themes:
Nutrition, hygiene, continence, freedom from
infection, security, self-esteem, role, attractiveness,
relationships, intimacy, clear-mindedness, pleasure,
and autonomy
* Data analysis is outlined as described in the original article. Note: BME = black and minority ethnic, IBD = inflammatory bowel disease, CD = Crohn’s disease, UC = ulcerative colitis.
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2.7. Data Analysis, Synthesis, and Interpretation
Examination of the data moved through a cyclical process involving description,
analysis, synthesis, and interpretation [32]. Descriptive comparisons of characteristics and
findings across studies were used to compare and contrast study narratives as they sat
alongside one another. Next, a detailed line by line coding of the data was conducted to
note initial impressions of meaning. These codes were examined together to develop first
order themes which described key dimensions of stigma occurring across studies. From this
template, patterns were identified and examined across data to gain deeper insight into
how the studies were positioned in relation to each other. Initial descriptive themes were
drawn together into composite second order themes. These were constructed through
an iterative process of moving between the original data, coding notes, and thematic
frameworks to explore commonalities and differences across the studies. A matrix was
used to record first and second order themes and their prevalence across studies.
In the final stages, themes were compared and condensed to generate third order
themes. Here, the researchers sought to move away from aggregation, towards a novel
interpretative understanding of the underlying processes and mechanisms related to
the lived experiences of stigma in IBD. This was achieved through a process of careful
consideration and reframing of underlying ideas and concepts, alongside revisiting original
data. Across all stages of the analytic process, the authors were mindful to stay true to the
voices of participants included in the synthesis. The final thematic structure was developed
by K.M, supported by continual discussion, reflection, and checking with E.J. and A.D.
3. Results
The synthesis resulted in the development of two core categories of themes (see
Table 3). ‘The IBD journey’ reflects the changing ways participants felt about themselves
as a person living with IBD and the varying impact stigma has had on their sense of self.
‘A need to be understood’ describes the impact of IBD on the feeling of integration and
connection within their social world. These themes are situated within an overarching
concept ‘Feeling of Otherness’: feeling of difference and alienation from their lives and those
around them. The distribution of themes across included papers are presented in Table 4.
All quotations are drawn from study participants, unless labelled as an ‘author comment’.
Table 3. Categories, themes, and overarching concept.
Category Theme Overarching Concept
The IBD journey




A need to be understood
A shameful secret
Knowing is not understanding
Social estrangement
The freedom of authenticity
3.1. The IBD Journey
This category of themes relates to the shifting ways in which having IBD impacted on
individual’s self-identity. The disease became a central part of life, not only influencing
how others viewed them but also how they viewed themselves. Narratives describe the
ongoing personal journeys following a diagnosis of IBD. At times people felt the IBD
label overshadowed and diminished them. Feelings of loss and shame accompanied an
understanding of the self as a damaged and lesser version of a former self. Individuals
described a process of re-building and recovery as they came to accept IBD as part of the
self and sought a new sense of meaning, value, and self-worth.
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Table 4. Distribution of themes across studies included in the review.
The IBD Journey A Need to Be Understood













Alexakis et al. (2015) [54] 3 3 3 3 3
Barned et al. (2016) [40] 3 3 3 3 3 3
Brydolf and Segesten (1996) [52] 3 3 3 3 3
Carter et al. (2020) [55] 3 3 3 3 3
Cho et al. (2018) [56] 3 3 3 3
Cooper et al. (2010) [57] 3 3 3 3
Czuber-Dochan et al. (2012) [58] 3 3 3 3 3 3
Czuber-Dochan et al. (2020) [59] 3 3 3 3 3
Daniel (2002) [43] 3 3 3 3 3
Demitras (2021) [41] 3 3 3 3
Devlen et al. (2014) [44] 3 3 3 3 3
Dibley et al. (2014) [29] 3 3 3 3 3 3
Dibley et al. (2018) [23] 3 3 3 3 3 3 3
Dibley et al. (2020) [28] 3 3 3 3 3 3 3
Dudley-Brown (1996) [42] 3 3 3 3 3
Frohlich (2014) [30] 3 3 3 3 3 3
García-Sanjuán et al. (2017) [45] 3 3 3 3 3 3
Hall et al. (2005) [60] 3 3 3 3 3 3 3
Jordan et al. (2017) [61] 3 3 3 3 3 3
Larsson et al. (2016) [62] 3 3 3 3
Lynch and Spence (2008) [46] 3 3 3 3 3 3
Matini and Ogden (2016) [47] 3 3 3 3 3
Mikocka-Walus et al. (2020) [53] 3 3 3 3 3
Moore (2013) [63] 3 3 3 3 3 3 3
Mukherjee et al. (2002) [48] 3 3 3 3
Nicholas et al. (2007) [49] 3 3 3 3 3 3 3
Norton et al. (2012) [39] 3 3 3 3
Nutting and Grafsky (2017) [64] 3 3 3 3 3 3
Lesnovska et al. (2010) [65] 3 3 3 3 3 3
Lesnovska et al. (2016) [66] 3 3 3 3 3 3
Purc-Stephenson et al. (2014) [50] 3 3 3 3
Richard et al. (2020) [51] 3 3 3
Ruan et al. (2020) [67] 3 3 3 3 3 3
Ruan and Zhou (2019) [68] 3 3 3 3 3 3 3
Sammut et al. (2015) [69] 3 3 3
Saunders (2014) [31] 3 3 3 3 3
Vejzovic et al. (2018) [70] 3 3 3 3 3 3 3
Wilburn et al. (2017) [71] 3 3
3.1.1. Reduced to a Label
This theme describes the experience of being defined primarily by a disease label.
The IBD label was forefront in individuals lives, branding them as different. Participants
felt IBD overshadowed all other aspects of self, impacting on other’s view of them and
how they interacted with them as a person. This undermined their individuality and
weakened their sense of being a whole person, giving the impression of being reduced
to “just becoming identified by a stomach problem” [60]. Resentment arose when other
people enabled the disease to eclipse the individual in this way:
“[The] consultant gave me a [national support group] leaflet and said, ‘You should
get in touch because they’re very helpful for people like you.’ I remember walking
out of the room thinking, ‘people like me?’ What the hell is he talking about?
It took me ages to work out why that rubbed me up the wrong way. He was
separating me out from the crowd and putting me in a box that went, ‘people
like you over there. You’re not here, you’re over there’.” [23]
Some adopted the label of IBD as a central focus of their own self-identity, it came to
define how they identified themselves as a person. They viewed themselves as being the
disease. This was a devaluing experience, diminishing their sense of self and making them
feel like less of a person:
“It made me feel like it’s not colitis and Andrea, it’s Andrea with colitis, ya know,
I was always putting it like at the front of my mind when I shouldn’t have been,
I should have been thinking of myself more.” [47]“I can’t live like this . . . I don’t
want to be a disease; I just want to be me.” [66]
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3.1.2. The Spoiled Self
This theme illustrates the division between being ‘healthy’ and being ‘ill’. People
compared themselves to their peers, positioning themselves as different and inferior. There
was also a struggle to reconcile this aspect of selfhood with who they had understood
themselves to be prior to having the disease. With this experience of alienation from the
former self and others came the idea of being “damaged in some way” [43]. Value laden
judgements were entrenched in the descriptions of the self as an unhealthy, diseased person
who was tarnished by IBD. This provoked feelings of shame, guilt, and inadequacy:
“You just feel like you are different . . . you’re not a healthy person anymore.
I just feel like an unhealthy person, so it just makes me feel like . . . I’m not good
enough in a way.” [56]
“I doubted myself, I doubted my value, I doubted my worth, I doubted my
capability.” [71]
Being unable to fulfil daily school, work, and family roles was related across accounts.
Individuals reflected on feeling incapable and burdensome because they were unable to
meet their own and other people’s expectations:
“I hate that I can’t handle having a full time job and having my kids. I don’t feel
like I’m living up to the standards that I want for wife and mom, that’s one of my
biggest struggles.” [64]
Experiencing physical symptoms of IBD or side-effects from medications served as a
reminder of the disease, evoking a feeling of being damaged. Individuals expressed con-
cerns that visible marks of the disease such as weight change, scars, and skin sores would
make them “look sickly” [49] and highlight what they felt was an ugly and unattractive
illness to others. Internal experiences such as fatigue and pain also prompted internal
dialogue of the self as a diseased person. Well intentioned expressions of sympathy or
pity further compounded divisions by projecting images of sickness and fragility upon the
person:
“My parents have never made any demands on me. I think this is negative.
My mum felt pity about me. She has been coddling me all the time. I became
more and more sad.” [52]
3.1.3. Re-Building the Self
This theme is about an ongoing process of re-building and recovery after a diagnosis of
IBD. Narratives described a significant shift from the person individuals identified as prior
to having IBD to who they felt they were after they received the diagnosis. People spoke
of moving between striving to “regain normality” (author comment) [68] and acceptance
of IBD as part of who they were. Some began to incorporate the life-long disease into
their self-identity:
“It’s not going to go away, better it stays part of me, but I don’t want it to define
me.” [53]
Acceptance of IBD was especially hard for those who expressed loss of an integral
part of the self and fought against what they felt was a lesser, sullied version of themselves:
“I don’t want to be considered “unhealthy.” What do I want? Empathy? Support?
A visible symptom? I wouldn’t say no to any of them, but what do I really
want? I just want me back.”; “I stand there facing the mirror. Not recognizing
its reflection. Not wanting to recognize it. It’s not me. This is not me. Who am I
kidding? This is what you have become. This is what’s left of you. Is this really
me now?” [63]
Accounts spoke of drawing on personal strengths and sources of private and pro-
fessional support to re-build self-worth. Some rejected ideas of being a devalued person,
showing defiance in the face of others’ negative or pitying attitudes. Others observed
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that discrimination and intolerance they faced helped them grow into a stronger person.
In reconstructing the self, new aspects of the self were uncovered from which individuals
regained mastery and derived value. In many accounts self-worth was gained from being
able to channel the experience of living with IBD into being able to show compassion and
support to others:
“I’ve helped a lot of people with Crohn’s and connected with them. I think maybe
that’s what I’m here for. To help people dealing with the same thing . . . ” [64]
3.2. A Need to Be Understood
Woven throughout this category is the need to be understood. Accounts conveyed
a strong need to be seen by others: for others in their lives to not only recognise but
also make sense of their experiences of living with IBD. Yet individuals’ true experiences
and perception of who they were as a person with IBD were often either hidden from
or misunderstood by those around them. Accounts conveyed a lack of belonging to
the wider social sphere, leaving people feeling isolated and marginalised. However,
when individuals felt safe enough to be truly authentic with others, being understood was
a liberating experience which fostered social connection.
3.2.1. A Shameful Secret
Having an unseen disease meant others were not aware of and so could not under-
stand the daily struggles individuals with IBD experienced, unless explicitly told. However,
individuals lacked safe spaces in which they could reveal this hidden disease. This reluc-
tance to fully disclose seemed to arise from a perception of disgust surrounding IBD as a
disease. There was an idea that the nature of IBD being associated with the bowels and
faeces made it a dirty disease, with many expressing revulsion at the nature of what they
felt to be “gross and disgusting” [39] symptoms. Having IBD made people feel unclean
and ashamed, driving them to limit what they shared or to conceal the disease altogether
to avoid anticipated negative judgements from others:
“It comes from me and how I feel about [colitis]; I think it’s disgusting, horrible,
and smelly—going to the toilet all the time and seeing all this gunk and blood
and mucus. I think it’s disgusting, so I guess if people knew the full extent of
what I see every day, they would think the same.” [23]
Strategies such as diet restriction, staying close to toilets, and carrying spare clothes
were employed to hide symptoms, even when these were detrimental to health. Others
avoided situations where them having IBD would be uncovered:
“When I have to use the bathroom in the house of someone who is not a member
of my family, I worry that the people there are thinking ‘look at him, coming to
my house to constantly use my WC’, so I look for other alternatives because I
don’t want people to think I’m dirty or weird’.” [45]
Social rules relating to the distastefulness of discussing bowel habits were also raised.
There was the impression that “some turn their noses up though when you talk about
poo and wee and blood and stuff” [60]. This gave people the sense that they did not have
permission from others to voice their experiences of IBD.
Living with the perpetual threat of being exposed as dirty and disgusting loomed
over those who felt that IBD was a shameful secret. This was further exacerbated by the
sporadic and unpredictable nature of symptoms, which made going out feel like “going
into the unknown” [47]. Participants accounts conveyed anxiety, tension, and exhaustion
underlying this ongoing concealment:
“I can’t tell you, talking about it is terrible because when I’m ill I don’t go out,
I can’t face it. Whenever you go to use public toilets you’re never in a contained
area. I can’t cope because of what everybody will think.” [57]
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3.2.2. Knowing Is Not Understanding
This theme draws a distinction between knowing that somebody has IBD and really
understanding the impact it has on their lives. As one person said “I think they don’t
understand. They know I have this disease but they don’t know how it affects me.” [59].
A lack of awareness about IBD made it challenging and effortful to explain the disease to
others. Accounts highlighted that varying misconceptions and prejudices about the nature
of IBD created a further barrier to understanding, preventing people from receiving the
recognition, validation, and support they craved. Some felt their experiences of having IBD
were dismissed, minimised, or trivialised by those who did not recognise the enduring
nature and severity of the disease. Others felt discredited and blamed for a problem that
was perceived to be self-inflicted. Some accounts spoke of a fear that others believed they
would be tainted or contaminated by coming into contact with the disease: “they say ‘Oh
my God can I catch it off you?’” [55]. Individuals voiced a feeling of being devalued and
condemned by these views, provoking intense reactions of frustration, pain, and loneliness:
“a prejudice of sorts that they have against me is when they say . . . come on,
it’s just your stomach . . . they can’t understand, they go to the toilet like once
every other day . . . ahh . . . I can’t keep it inside me . . . I just need to put up with
it, so . . . it’s actually hard [tears start coming].” [70]
“No one in my life understands what I am going through and strangers judge
you and think you are contagious or disgusting.” [50]
Misconceptions were felt especially keenly when they came from close family mem-
bers or healthcare professionals. It seemed that it was particularly damaging to feel
misunderstood by those who were either part of one’s closest social circle or were expected
to fulfil a caring role and show a greater level of understanding, empathy and compassion:
“When I first came out of hospital the last time my nan just called it a dicky
tummy and I had IBS, so I felt pretty upset about that because that made me
feel really like they didn’t understand what I went through, and they should’ve
because they’re my family.” [47]
“Once I was admitted to casualty with acute pain and still he [the doctor] told
me that nothing was wrong. In the meantime I took tranquillizers and he [the
doctor] told me to continue taking them since I was having panic attacks. but I
knew that something was wrong... I began to doubt whether my family believed
me or not and I would fill up with anger.” [69]
3.2.3. Social Estrangement
This theme describes the isolation accompanying social estrangement. The physical
symptoms of IBD in combination with the stigma surrounding the disease disrupted how
individuals were situated in their world, eroding a sense of belonging. Management of
socially unacceptable and fluctuating physical symptoms and needs, especially around food
and use of toilet facilities, severely constrained engagement in daily living. In restricting
the ability to fully participate, having the disease made people feel excluded from these
parts of their life. Shame about having what was felt to be a dirty and unclean disease
provoked a sense of not being entitled to inhabit the same space. Feelings of loss and regret
emerged from disconnection from parts of life which would ordinarily foster feelings of
unity and shared identity:
“It’s just the way the ethnic community is and with food and obviously food is a
big part of the culture . . . everything is based around food, weddings are based
around food, you go into people’s houses, it’s all about bringing as much food as
you can and that’s what entertaining is . . . It is a different culture and just, you
know, you will stand out . . . because you’re not eating.” [54]
Individuals felt ostracised for having symptoms which contravened societal expec-
tations of normality and acceptability, including different diets, poor bowel control, loud
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or badly smelling bowel movements, taking medication, and use of feeding tubes. Some
spoke of being “isolated and ridiculed” [49] by peers or family, who teased and bullied
them. This was particularly apparent in accounts from young people. Even when overt
social rejection was not directly experienced, there was strong fear that others may still be
“mentally backing away” [23] because they are thinking badly of them:
“They don’t necessarily have to react badly, but if I think that they’re thinking
something then . . . ” [55]
This feeling of exclusion was at times exacerbated by misplaced attempts of adaptation
and support:
“At work they assigned me to places where I was on my own, so that I could easily
go to the bathroom. In that way I would not hinder the work production.” [69]
Comfort was sought by retreating to the safety of familiar surroundings. There was a
pessimism underlying this, an idea that it was futile to try and be part of a social world
where others either could not or would not accept or understand you. Although intended
to serve as a protective factor, withdrawal created further barriers to social integration,
inhibiting development of deeper bonds and leaving people feeling even more trapped
and alone:
“People don’t get it, and I don’t expect them to, I guess. But, sometimes it’s easier
just to not deal with it, and just stay in our little section, our little corner, on the
farm, and be comfortable.” [64]
“Relationships and friendships have suffered a great deal. I’ve found that my
circle of friends and family members have very little understanding of IBD.
Because of this I feel isolated and mostly keep to myself in my spare time.” [50]
3.2.4. The Freedom of Authenticity
There was tension in narratives between wanting people to understand and yet finding
it too difficult, embarrassing, or shameful to be fully authentic and reveal the realities of
living with IBD. Despite a strong need to feel heard, validated, and supported, many still
felt driven by lack of understanding and fear of judgement or blame to hide this part
of themselves:
“I’ve wondered if it would help if he [partner] knew a little more. But I don’t
know, I don’t want to say all these symptoms, so many of them are gross. [If I
communicated more] maybe he would be more empathic.” [64]
“When I could not tell (I had Crohn’s disease), I felt really stressed. I also wanted
them (my friends) to understand why I could not travel with them. However, I
could not tell the truth.” [67]
There was a palpable sense of relief when people were able to overcome this struggle
and not only share their true experiences but be their true selves. Being authentic was
liberating and empowering. As one person noted: “You kind of have that freedom once
you tell people. You don’t have to hide it anymore” [30]. It was easier for people to let their
guard down in the context of trusted and supportive friendships or family environments,
where they felt safe enough to offer this level of openness. The intimacy of full disclosure
helped individuals feel understood by and re-connected with others:
“I think if anything those friends have become closer because I think they feel
I’ve shared a lot more with them now because they know so much about it and
they know how hard it’s been, they’ve been there in the hospital and wherever
else and they’re still with me when I feel terrible so they see it face to face.” [47]
Empathy and support were also gained from others who also had a diagnosis of IBD
and therefore had similar lived experiences. When somebody shared this experience, many
of the barriers to authenticity were broken down, allowing shared understanding. This
was affirming and supported individuals to feel reconnected:
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“I met someone at work who also had UC. And it was good to talk to someone
who understands exactly my situation. It made me feel less alone with this
problem.” [62]
3.3. Overarching Concept: Feeling of Otherness
The two core themes are nested within an overarching concept of otherness. Other-
ness was a lens through which individuals experienced their lives and interacted with the
world around them. It was a subtle and insidious form of estrangement and devaluing
which impacted across individuals lives. Otherness influenced individual’s engagement
in the world around them and permeated the language and behaviour of friends, family,
colleagues, and healthcare professionals, separating those with IBD out as being different.
It also shaped how individuals with IBD viewed themselves, resulting in a feeling of
disconnection between the ‘ill’ self and a former ‘healthy’ self. Yet this stigmatising experi-
ence of otherness was variable rather than static. Across time and situations, individuals
fluctuated between the separation of otherness and inclusion of integration. This was
influenced by disease activity, previous experience of coping, quality of support networks,
others’ actions and words, expectations of others’ views, awareness, and knowledge of IBD,
and the social situation. A feeling of integration was derived by re-building a valued sense
of self and through authentic social connection to others who were aware of, understood,
and accepted the individual for who they were. Central to this was acceptance of an
inclusion of IBD in the individual’s internal and external world. Whilst the experience of
otherness was marked by profound isolation and exclusion, the experience of integration
was accompanied by freedom and empowerment.
4. Discussion
This synthesis draws together findings from 38 studies describing lived experiences
to provide insight into when, how, and why stigma impacts those with IBD. The two
core themes incorporated the interconnected personal and social journeys that individuals
with IBD embarked on following diagnosis. Stigma was a common experience within
these journeys, involving intrapersonal, interpersonal, and community level processes
of exclusion, separation, withdrawal, isolation, and judgement [72]. Themes within ‘the
IBD journey’ explore the diminishing experience of being ‘reduced to a label’, the shame
accompanying an understanding of the self with IBD as ‘the spoiled self’, and a process
of recovery and self-acceptance within ‘re-building the self’. Themes within ‘a need to be
understood’ consider the distressing experience of feeling driven to keep a ‘a shameful
secret’, the painful impact of feeling misunderstood in ‘knowing is not understanding’,
the sense of ‘social estrangement’ arising from a lack of social belonging, and finally in ‘the
freedom of authenticity’ the comfort gained from authentic connection with others.
Stigma had broad health and social impacts on wellbeing, self-worth, identity, qual-
ity of life, social relationships, healthcare interactions, illness management, working life,
and education. In line with the multi-faceted conceptualisation of stigma [17], a distinc-
tion can be drawn between the experience of enacted, perceived, and internalised stigma.
Perceived stigma has been reported to commonly occur in IBD [19,20] and has an adverse
impact on mental health and wellbeing [73,74]. Perceived stigma was highly prevalent
throughout this synthesis. The themes ‘knowing is not understanding’ and ‘social es-
trangement’ describe a perception that others hold negative views around disgust, blame,
condemnation, or dismissal towards people with IBD, due to the unclear cause and nature
of the disease relating to the bowels. This view resulted in intense emotional reactions
of anxiety, frustration, pain, and loneliness, indicating that perceived stigma may have a
similarly harmful impact on psychological functioning as in other long-term conditions
such as HIV/AIDS and mental health [75,76]. Enacted stigma is reported as less common
than other forms of stigma in IBD [19,20]. Although teasing, bullying, and being ridiculed
was evident within the theme ‘social estrangement’, such forms of explicit discrimination
were less frequent and mostly limited to young people’s accounts. However, more subtle
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forms of discrimination were evident within the ‘spoiled self’, which speaks of an image
of sickness or fragility being projected upon individuals by others treating them as less
capable, misplaced attempts of adaptation and support, and unwelcome demonstrations
of pity. Thus, less overt and intentional discrimination may be more widespread in IBD
than previously considered.
Enacted and perceived stigma were reported from peers, co-workers, friends, family,
healthcare providers, and the general public. However, within ‘knowing is not understand-
ing’ it can be seen that concern about those closest to them demonstrating prejudice or
holding stigmatising views appeared most damaging. In the face of feeling stigmatised,
people frequently cited close social networks as crucial sources of support. Yet when
family and friends were unable or unwilling to provide empathy or themselves showed
stigma, there was an increased sense of stigma burden which further impeded wellbeing
and placed a heavy strain on those important relationships. This supports the suggestion
that kinship stigma (negative or discriminatory attitudes towards individuals by family
members and their closest relationships) can have an intense emotional impact [23,28].
Additionally, perceived or enacted stigma from healthcare professionals was also experi-
enced as being particularly distressing. This suggests that the detrimental effect of stigma
is greatest from those in positions expected to be supportive, empathic, and understanding,
whether that is family, friends or healthcare providers.
Mild levels of internalised stigma were reported previously in IBD [19,20] and have
been linked with the poorest psychological outcomes of the three stigma domains [20],
especially when accompanied by shame [19]. In this synthesis, internalised stigma was
strongly apparent across the themes ‘reduced to a label’, ‘the spoiled self’, and ‘a shameful
secret’, where accounts conveyed the shameful experience of viewing the self with IBD
as diminished and dirty. Internalised stigma has been reported as more prevalent in IBD
during an active disease phase [20]. Findings from this synthesis indicate this may be due to
physical symptoms serving as a reminder of IBD and evoking internal dialogue of the self
as dirty and damaged. The socio-cognitive model provides a framework for understanding
the process by which some people came to hold negative self-views: through stereotype-
awareness, stereotype-agreement, and self-concurrence [77]. Accounts in this review show
that individuals were aware of and sometimes held negative societal stereotypes about
dirtiness and disgust surrounding bowel functions before they received an IBD diagnosis.
Awareness was further heightened following diagnosis, with individuals assuming that
negative views would be shared by others. Those who internalised negative stereotypes
viewed them as legitimate and felt they applied to them as somebody with a bowel disease,
diminishing their self-esteem, and making acceptance challenging.
The overarching concept ‘feeling of otherness’ highlights that, rather than a static,
binary experience, individuals moved back-and-forth along a continuum, ranging from
the excluding experience of otherness, to the inclusive experience of integration. Inte-
gration involved intrapersonal and interpersonal processes of freedom, empowerment,
empathy, validation, and belonging, giving rise to feelings of relief, acceptance, and being
valued. Studies have differentially reported that length of disease duration is associated
with a reduction, increase, or no change in levels of stigma [19]. These mixed findings
may reflect the fluctuating nature of stigma in IBD, which varies across physical, social,
and health contexts within which the individual is situated. Flare-ups in particular brought
an increased susceptibility to stigma as they evoked a self-concept of a ‘spoiled self’ and
increased fear of others noticing symptoms as considered in ‘a shameful secret’. Movement
towards integration was supported through the process of psychological adjustment to
IBD apparent within ‘re-building the self’ and reconnecting with valued others through
illness disclosure as explored within ‘the freedom of authenticity’. Drawing on experience
of adaptive coping further strengthened these forms of stigma resistance during more
challenging times.
This synthesis suggests that psychological adjustment to IBD plays a key role in
protecting individuals from the detrimental effects of stigma. Positive adjustment to a
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chronic illness is a transitional process involving acceptance of the illness, incorporation of
it into the existing sense of self, and sometimes self-growth [78]. In the current synthesis,
being diagnosed with IBD caused individuals to feel ‘reduced to a label’, devaluing them
and consuming their self-identity. In viewing themselves as a ‘spoiled self’, they felt
tarnished and alienated from their former self. However, by accepting and incorporating
IBD into their identity, as a part rather than the whole, they were able to embark on the
process of ‘re-building the self’ and recover feelings of self-worth. For some, having IBD
also uncovered new aspects of the self from which they derived value. As with other
fluctuating conditions [78], living with ongoing unpredictability and uncertainty made
acceptance especially challenging. This aligns with the “push and pull” phenomenon
identified by Kemp and colleagues [8], with the fluctuation of disruption to life trapping
individuals in a cycle of pushing for normality but being pulled back from this by the
disease. Thus, acceptance of IBD may mean acceptance of multiple, shifting versions of
“normality”. This process may be more difficult for those who experience internalised
stigma, as those who felt shame about what was understood to be a ‘spoiled self’ struggled
with acceptance.
Within this synthesis, stigma provoked a number of unhelpful avoidance-based coping
strategies. The themes ‘a shameful secret’ and ‘social estrangement’ examine a complex
convergence of fear that others would not accept or understand the disease, the taboo
nature of the symptoms, worry that others would think they were unclean due to the nature
of the symptoms relating to the bowels, and a feeling of being dirty due to having IBD, all of
which prompted avoidance and social withdrawal. These cycles of avoidant behaviour
exacerbated feelings of difference and further trapped and disempowered individuals,
thereby fuelling anxiety and low mood. Whilst such maladaptive coping strategies have
been linked to poorer psychological health for those with IBD, use of more adaptive coping
styles are associated with higher wellbeing and quality of life [79]. Within this synthesis,
individuals who were able to draw on previous experiences of adaptive coping were more
able to cope with the demands of living with a stigmatised illness. Within ‘freedom of
authenticity’ this took the form of seeking social support and within ‘re-building the self’
in positively reappraising the situation. The ability to identify and flexibly apply a range of
adaptive coping strategies may support resilience to the impacts of stigma [80].
A challenging decision for many individuals diagnosed with an invisible illness is
how and when to disclose to others. ‘A shameful secret’ highlights that feelings of shame
associated with believing that IBD was a dirty, disgusting disease that others would also
view negatively compelled some to employ strategies that were detrimental to their own
health and wellbeing to facilitate concealment. Hiding the disease inhibited individual’s
ability to build effective support networks, a known outcome of concealment in other
stigmatising health conditions [24,81]. It was also difficult and effortful to conceal IBD
from others due to ‘flare ups’ and noticeable impacts on life such as missing social events,
leaving people feeling vulnerable to ‘involuntary’ disclosure [82]. Disclosure was made
more challenging by the lack of public knowledge and understanding about IBD [83] and
societal norms which dictate that the bowels and faeces are not something that should be
discussed in social settings [24]. However, within ‘freedom of authenticity’ we see that
some individuals felt able to disclose their illness experiences and support their social
network to understand this new part of their life. This resulted in feelings of liberation
and empowerment, supporting their recovery from social disconnection. Such voluntary
and planned disclosure of stigmatised diseases is recognised as a crucially important
factor in patient health and wellbeing [82]. However, it was not only disclosure of the
diagnostic label but full disclosure of the impact of this disease which seemed key in feeling
understood and connected to others.
4.1. Implications and Recommendations
There may be multiple pathways through which perceived, enacted, and internalised
stigma leads to negative outcomes for individuals with IBD. As such, a multi-level ap-
Int. J. Environ. Res. Public Health 2021, 18, 8038 22 of 28
proach targeting stigma at the intrapersonal, interpersonal, and structural level may be
required [84]. Psychological support could be used to help individuals with IBD cope
with stigma. Cognitive-behavioural therapy (CBT) has been found to reduce internalised
stigma and improve psychological and social functioning for people with stigmatised
mental health conditions [26]. CBT-based interventions in IBD could target unhelpful
avoidance or withdrawal strategies, support use of more adaptive coping strategies, enable
re-appraisal of self-stigmatising beliefs, and facilitate individual’s adjustment to living
with IBD. The disparity between perceived and enacted stigma suggests individuals may
overestimate the threat of stigma from others and raises the potential of re-examination
of threat-appraisals. Navigating the complexities of the disclosure process and helping
individuals with IBD decide when, to whom, and how to disclose their diagnosis will
also be important [82]. Supportive disclosure may also have the additional benefit of
improving interpersonal interactions and therefore reducing stigmatising attitudes of oth-
ers [84]. Acceptance-based CBT approaches such as Acceptance and Commitment Therapy
and Mindfulness-Based Cognitive Therapy may also address unhelpful avoidance-based
coping strategies as well as fostering greater self-compassion and acceptance of living
with IBD [85,86]. For some, a systemic approach may be beneficial in establishing helpful
connections, coping, and adaptation to IBD within individuals’ family systems [87]. Given
the fluctuating and context-dependent nature of stigma in IBD, psychological interven-
tions could usefully be employed at the time of diagnosis, to foster skills for building
stigma resistance and reduce the likelihood of more significant psychological difficulties
developing. Developing resource-light interventions is important given that psychology
provision within gastroenterology services is often under-resourced. High acceptability
of electronic psychological interventions has been reported in those with IBD [88], indi-
cating potential for less costly computerised interventions. Individuals in the current
synthesis reported that support from others with lived experience was valuable and re-
search has shown that meeting others with the same or similar conditions can provide
information and emotional support [89], thus group-based formats may be valuable and
cost-effective. Additionally, healthcare settings could increase advertising and engagement
in online peer support networks established by charities for people with IBD (e.g., cicra.org,
crohnscolitisfoundation.org, crohnsandcolitis.org.uk).
Education-based interventions could target stigmatised views in the community.
Within this synthesis, the development of stigma related to IBD appears to stem from
societal ideas that faeces and defecation is an inherently dirty and disgusting process,
which should not be discussed or in any way be made public, almost that engaging in this
vital bodily function should be denied and viewed like a dirty secret. Educational interven-
tions could be used to refute negative stereotypes surrounding the bowels by presenting
information contradicting stereotypes or by creating cognitive dissonance, which have
been effective in changing attitudes and behaviours towards individuals with HIV/AIDs
and mental health problems [84]. Participants in this synthesis believed there was a gen-
eral lack of awareness and understanding about IBD, a viewpoint which is illustrated in
studies demonstrating a lack of knowledge of IBD in the general public [90]. Increased
understanding of IBD would likely make disclosure easier as well as reducing stigma
and prejudice views, as has been shown in relation to mental health difficulties [91,92].
As well as targeting negative stereotypes, educational campaigns could discuss how best to
support individuals with IBD. As misplaced efforts to provide support can be experienced
as stigmatising, this may reduce unintentional enacted stigma. Supporting family members
and important others to understand IBD and the experience of living with it could be espe-
cially important, allowing them to perform a key supportive role. Involvement of experts
by experience in development and delivery of educational material will be key, as in-
cluding contact with someone with the stigmatised condition improves the effectiveness
of awareness-based interventions [84]. The ‘it takes guts’ campaign (ittakesguts.org.uk)
showcases important work which has already begun in providing a platform for such
conversations. Healthcare providers may also benefit from further education about IBD
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from a lived experience perspective, as individuals in the synthesis found it especially
difficult when healthcare providers were less empathic than expected. Understanding of
the psychosocial impact of IBD in particular may be limited within GPs [93] and the impact
of IBD on daily functioning has also been found to be underestimated in gastroenterol-
ogists [94]. Communication training may support busy medical professionals consider
effective ways of talking about IBD with patients in clinic, to help prevent unintentionally
indicating a lack of interest or recognition of the impact of IBD on their patients’ lives.
Finally, rather than challenging stigma, resources could be used to support parents and
teachers to promote positive schemas about bowel functioning during early development.
Similar early stigma interventions have been found to be effective in promoting positive
childhood attitudes in the context of mental health [95]. Early work to prevent the develop-
ment of taboos and shame around defecation may be more effective than later attempting
to dismantle negative stereotypical views which have become more fixed. This may also
protect against internalised stigma by reducing the likelihood of stereotype endorsement
following a diagnosis of IBD. Reducing the taboo around bowel functioning and the inter-
nalised stigma that can come with IBD has the potential to alleviate some of the burden of
living with IBD and improve patient’s health-related quality of life.
Findings from this synthesis highlight important avenues for future exploration.
There is a need to investigate the occurrence of subtle discriminatory practices towards
those with IBD and the impact this form of enacted stigma may have on individuals’
lives. It would be useful to examine the differential occurrence, experience, and impact
of perceived and enacted stigma from different sources to further explore the concept
of kinship stigma and whether this extends to healthcare professionals. Research could
examine what supports individuals to develop resistance to stigma in IBD, in particular
resistance to internalised stigma and a reduction in perceived stigma. Finally, the review
highlighted a paucity of research sampling children or adolescents. Yet the prevalence of
paediatric onset IBD is rising [96], with approximately one quarter of IBD cases presenting
before adulthood [97]. Reports in this synthesis of teasing or bullying related to IBD were
more apparent amongst paediatric populations, suggesting there may be distinctions in
the type of stigma experienced by young people. Stigma may be particularly impactful in
this group, as adolescence is a crucial age for social development where peer judgments
have a strong influence on far reaching aspects of self-hood, including perceptions of
social and personal worth [98]. Increased appraisals of IBD stigma have been shown to be
associated with reduced perceptions of social belongingness, resulting in higher rates of
depressive symptoms in an adolescent population [99]. It could therefore be valuable to
better understand the experience of stigma in this population.
4.2. Strengths and Limitations
One of the key strengths of this review is the large sample of participants accounts
that were drawn upon to provide a rich and detailed narrative of the lived experiences of
stigma in individuals with IBD. Despite a reasonable level of diversity amongst included
participants in terms of gender, ethnicity, sexuality, age, disease length, and disease activity,
findings demonstrate many commonalities in the experiences of stigma and the mecha-
nisms through which it operates. However, findings must be viewed within the context of
the study limitations. First, findings were drawn from published quotations and author
interpretations from included studies and therefore analysis did not involve examination
of the original raw data. Second, only including studies published in English language
means that evidence published in other languages was not incorporated. Third, although
three studies were conducted in China and Hong Kong, the majority of studies included
a Western sample. Given the rise of IBD in newly industrialised countries [3], it will be
important to understand any differences in the experience of stigma for those with IBD
across different cultural contexts.
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5. Conclusions
This synthesis highlighted the complexity of stigma and IBD; different forms of stigma
are apparent, each with the potential to impact on the individual’s physical and mental well-
being in different ways, including low mood, social withdrawal, and reduced self-esteem.
Perceived and internalised stigma were more commonly reported than enacted stigma.
Whilst some of the adolescent population reported teasing and bullying, for adults enacted
stigma was often viewed as misplaced attempts to be supportive or a lack of awareness
and understanding. Kinship stigma, and stigma from healthcare professionals, appeared
to be the most challenging for individuals due to them having greater expectations of
understanding and empathy within these valued relationships. Stigma was not a binary
experience; individuals fluctuated along the continuum between feeling stigmatised and
othered and feeling integrated and connected dependent on disease activity and different
social and environmental contexts. Psychological adjustment to IBD, the use of adaptive
coping strategies, and illness disclosure were important protective factors. Development
and implementation of interventions to support individuals who experience IBD-related
stigma and to foster stigma resistance will be important. Interventions could also seek
to reduce IBD-related stigma by providing education for families, social networks, and
healthcare providers on the psychosocial impact of IBD, and by implementing stigma
reduction interventions at a community level.
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